[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fWA7uM_AhkWI5wuwcstOMVdIaEX21OYP8x9b9f0F7dKg":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":36,"phaseBuckets":52,"rows":59},"Pennington Biomedical Research Center",[4],281,false,47,1,65421,3,252,[14,17,20,23,26,28,30,33],{"name":15,"count":16},"Obesity",49,{"name":18,"count":19},"Childhood Obesity",14,{"name":21,"count":22},"Insulin Resistance",12,{"name":24,"count":25},"Insulin Sensitivity",8,{"name":27,"count":25},"Weight Loss",{"name":29,"count":25},"Type 2 Diabetes",{"name":31,"count":32},"Overweight",7,{"name":34,"count":35},"Physical Activity",6,[37,42,47],{"nctId":38,"briefTitle":39,"date":40,"intervention":41},"NCT05919147","The Neuroendocrine Effects of Pioglitazone in Patients With Cancer and Cachexia","2025-06-30","Pioglitazone 45 mg",{"nctId":43,"briefTitle":44,"date":45,"intervention":46},"NCT06318507","The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy","2026-12-31","Fecal microbial diversity",{"nctId":48,"briefTitle":49,"date":50,"intervention":51},"NCT07154719","GLP-1R Actions on Muscle and the Skeleton","2027-02-01","Tirzepatide",[53,54,55,56,57,58],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[60,99,122,143,181,199,225,243,269,293,318,343,369,387,412,437,461,485,503,527,558,576,594,612,630,648,666,684,719,752,776,803,821,844,868,892,920,946,964],{"intervention":51,"totalTrials":61,"cells":62},2,{"EARLY_PHASE1":63,"PHASE1":66,"PHASE2":68,"PHASE3":70,"PHASE4":72,"NA":86},{"trials":64,"activeCount":65},[],0,{"trials":67,"activeCount":65},[],{"trials":69,"activeCount":65},[],{"trials":71,"activeCount":65},[],{"trials":73,"activeCount":9,"soonestReadout":50},[74],{"nctId":48,"briefTitle":49,"status":75,"phases":76,"primaryCompletion":50,"completion":77,"start":78,"enrollment":79,"conditions":80,"interventions":85},"RECRUITING",[57],"2027-05-01","2025-10-09",50,[81,15,82,83,84],"Musculoskeletal Abnormalities","Sarcopenic Obesity","Osteoporosis","Drug Effect",[51],{"trials":87,"activeCount":65},[88],{"nctId":89,"briefTitle":90,"status":91,"phases":92,"primaryCompletion":93,"completion":93,"start":94,"enrollment":95,"conditions":96,"interventions":98},"NCT05766358","Role Of Metabolic Adaptation In Weight Regain","COMPLETED",[],"2024-05-24","2022-10-06",27,[27,97,15],"Weight Gain",[51],{"intervention":41,"totalTrials":9,"cells":100},{"EARLY_PHASE1":101,"PHASE1":103,"PHASE2":105,"PHASE3":116,"PHASE4":118,"NA":120},{"trials":102,"activeCount":65},[],{"trials":104,"activeCount":65},[],{"trials":106,"activeCount":9,"soonestReadout":40},[107],{"nctId":38,"briefTitle":39,"status":108,"phases":109,"primaryCompletion":40,"completion":110,"start":111,"enrollment":112,"conditions":113,"interventions":115},"ACTIVE_NOT_RECRUITING",[55],"2026-06-30","2024-01-03",24,[114],"Lung Cancer",[41],{"trials":117,"activeCount":65},[],{"trials":119,"activeCount":65},[],{"trials":121,"activeCount":65},[],{"intervention":46,"totalTrials":9,"cells":123},{"EARLY_PHASE1":124,"PHASE1":126,"PHASE2":128,"PHASE3":130,"PHASE4":132,"NA":134},{"trials":125,"activeCount":65},[],{"trials":127,"activeCount":65},[],{"trials":129,"activeCount":65},[],{"trials":131,"activeCount":65},[],{"trials":133,"activeCount":65},[],{"trials":135,"activeCount":9,"soonestReadout":45},[136],{"nctId":43,"briefTitle":44,"status":75,"phases":137,"primaryCompletion":45,"completion":45,"start":138,"enrollment":139,"conditions":140,"interventions":142},[],"2024-03-11",25,[141],"Breast Neoplasms",[46],{"intervention":144,"totalTrials":61,"cells":145},"Sesame Oil",{"EARLY_PHASE1":146,"PHASE1":148,"PHASE2":150,"PHASE3":152,"PHASE4":154,"NA":179},{"trials":147,"activeCount":65},[],{"trials":149,"activeCount":65},[],{"trials":151,"activeCount":65},[],{"trials":153,"activeCount":65},[],{"trials":155,"activeCount":65},[156,169],{"nctId":157,"briefTitle":158,"status":91,"phases":159,"primaryCompletion":160,"completion":160,"start":161,"enrollment":162,"conditions":163,"interventions":167},"NCT04120363","Trial of Testosterone Undecanoate for Optimizing Performance During Military Operations",[57],"2021-07-08","2019-09-23",34,[164,165,166],"Caloric Restriction","Exercise","Sleep",[168,144],"Testosterone Undecanoate",{"nctId":170,"briefTitle":171,"status":91,"phases":172,"primaryCompletion":173,"completion":173,"start":174,"enrollment":175,"conditions":176,"interventions":177},"NCT02734238","Physiological and Psychological Effects of Testosterone During Severe Energy Deficit and Recovery",[57],"2017-12","2016-04",53,[164,165],[144,178],"testosterone enanthate",{"trials":180,"activeCount":65},[],{"intervention":168,"totalTrials":9,"cells":182},{"EARLY_PHASE1":183,"PHASE1":185,"PHASE2":187,"PHASE3":189,"PHASE4":191,"NA":197},{"trials":184,"activeCount":65},[],{"trials":186,"activeCount":65},[],{"trials":188,"activeCount":65},[],{"trials":190,"activeCount":65},[],{"trials":192,"activeCount":65},[193],{"nctId":157,"briefTitle":158,"status":91,"phases":194,"primaryCompletion":160,"completion":160,"start":161,"enrollment":162,"conditions":195,"interventions":196},[57],[164,165,166],[168,144],{"trials":198,"activeCount":65},[],{"intervention":200,"totalTrials":9,"cells":201},"divalproex sodium",{"EARLY_PHASE1":202,"PHASE1":204,"PHASE2":206,"PHASE3":208,"PHASE4":210,"NA":223},{"trials":203,"activeCount":65},[],{"trials":205,"activeCount":65},[],{"trials":207,"activeCount":65},[],{"trials":209,"activeCount":65},[],{"trials":211,"activeCount":65},[212],{"nctId":213,"briefTitle":214,"status":91,"phases":215,"primaryCompletion":216,"completion":217,"start":218,"enrollment":219,"conditions":220,"interventions":222},"NCT00287053","Effects of Divalproex Sodium on Food Intake, Energy Expenditure, and Posture Allocation",[57],"2006-09","2006-10","2006-02",57,[221],"Healthy",[200],{"trials":224,"activeCount":65},[],{"intervention":178,"totalTrials":9,"cells":226},{"EARLY_PHASE1":227,"PHASE1":229,"PHASE2":231,"PHASE3":233,"PHASE4":235,"NA":241},{"trials":228,"activeCount":65},[],{"trials":230,"activeCount":65},[],{"trials":232,"activeCount":65},[],{"trials":234,"activeCount":65},[],{"trials":236,"activeCount":65},[237],{"nctId":170,"briefTitle":171,"status":91,"phases":238,"primaryCompletion":173,"completion":173,"start":174,"enrollment":175,"conditions":239,"interventions":240},[57],[164,165],[144,178],{"trials":242,"activeCount":65},[],{"intervention":244,"totalTrials":9,"cells":245},"sibutramine, orlistat, diethylpropion",{"EARLY_PHASE1":246,"PHASE1":248,"PHASE2":250,"PHASE3":252,"PHASE4":254,"NA":267},{"trials":247,"activeCount":65},[],{"trials":249,"activeCount":65},[],{"trials":251,"activeCount":65},[],{"trials":253,"activeCount":65},[],{"trials":255,"activeCount":65},[256],{"nctId":257,"briefTitle":258,"status":259,"phases":260,"primaryCompletion":261,"completion":262,"start":263,"enrollment":264,"conditions":265,"interventions":266},"NCT00115063","LOSS- Louisiana Obese Subjects Study","TERMINATED",[57],"2007-12","2008-01","2005-07",390,[15],[244],{"trials":268,"activeCount":65},[],{"intervention":270,"totalTrials":9,"cells":271},"rhGH",{"EARLY_PHASE1":272,"PHASE1":274,"PHASE2":276,"PHASE3":278,"PHASE4":280,"NA":291},{"trials":273,"activeCount":65},[],{"trials":275,"activeCount":65},[],{"trials":277,"activeCount":65},[],{"trials":279,"activeCount":65},[],{"trials":281,"activeCount":65},[282],{"nctId":283,"briefTitle":284,"status":91,"phases":285,"primaryCompletion":286,"completion":286,"start":287,"enrollment":288,"conditions":289,"interventions":290},"NCT00453557","Mechanism of Growth Hormone Effects on Adipose Tissue",[57],"2000-12","1999-04",30,[15],[270],{"trials":292,"activeCount":65},[],{"intervention":294,"totalTrials":9,"cells":295},"Metformin",{"EARLY_PHASE1":296,"PHASE1":298,"PHASE2":300,"PHASE3":302,"PHASE4":314,"NA":316},{"trials":297,"activeCount":65},[],{"trials":299,"activeCount":65},[],{"trials":301,"activeCount":65},[],{"trials":303,"activeCount":65},[304],{"nctId":305,"briefTitle":306,"status":259,"phases":307,"primaryCompletion":174,"completion":308,"start":309,"enrollment":310,"conditions":311,"interventions":313},"NCT01482286","Effect of Weight and Insulin Sensitivity on Reproductive Function in PCOS",[56],"2016-12","2012-05",32,[312],"Polycystic Ovary Syndrome",[294],{"trials":315,"activeCount":65},[],{"trials":317,"activeCount":65},[],{"intervention":319,"totalTrials":9,"cells":320},"Prednisolone synthetic cortisone and Isoproterenol together",{"EARLY_PHASE1":321,"PHASE1":323,"PHASE2":325,"PHASE3":337,"PHASE4":339,"NA":341},{"trials":322,"activeCount":65},[],{"trials":324,"activeCount":65},[],{"trials":326,"activeCount":65},[327],{"nctId":328,"briefTitle":329,"status":91,"phases":330,"primaryCompletion":331,"completion":331,"start":332,"enrollment":333,"conditions":334,"interventions":336},"NCT00624416","Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas",[54,55],"2009-03","2007-10",10,[335],"Lipoma",[319],{"trials":338,"activeCount":65},[],{"trials":340,"activeCount":65},[],{"trials":342,"activeCount":65},[],{"intervention":344,"totalTrials":9,"cells":345},"Ephedrine",{"EARLY_PHASE1":346,"PHASE1":348,"PHASE2":350,"PHASE3":363,"PHASE4":365,"NA":367},{"trials":347,"activeCount":65},[],{"trials":349,"activeCount":65},[],{"trials":351,"activeCount":65},[352],{"nctId":353,"briefTitle":354,"status":91,"phases":355,"completion":356,"start":357,"enrollment":358,"conditions":359,"interventions":360},"NCT00377975","\"Pecos\" B-adrenergic and PPAR-G Stimulation Upregulates Lipid Metabolism in Human Subcutaneous Fat",[55],"2004-11","2003-01",96,[15],[344,361,362],"Pioglitazone","Caffeine",{"trials":364,"activeCount":65},[],{"trials":366,"activeCount":65},[],{"trials":368,"activeCount":65},[],{"intervention":362,"totalTrials":9,"cells":370},{"EARLY_PHASE1":371,"PHASE1":373,"PHASE2":375,"PHASE3":381,"PHASE4":383,"NA":385},{"trials":372,"activeCount":65},[],{"trials":374,"activeCount":65},[],{"trials":376,"activeCount":65},[377],{"nctId":353,"briefTitle":354,"status":91,"phases":378,"completion":356,"start":357,"enrollment":358,"conditions":379,"interventions":380},[55],[15],[344,361,362],{"trials":382,"activeCount":65},[],{"trials":384,"activeCount":65},[],{"trials":386,"activeCount":65},[],{"intervention":388,"totalTrials":9,"cells":389},"Metformin + PAP",{"EARLY_PHASE1":390,"PHASE1":392,"PHASE2":394,"PHASE3":406,"PHASE4":408,"NA":410},{"trials":391,"activeCount":65},[],{"trials":393,"activeCount":65},[],{"trials":395,"activeCount":65},[396],{"nctId":397,"briefTitle":398,"status":259,"phases":399,"primaryCompletion":400,"completion":400,"start":401,"enrollment":402,"conditions":403,"interventions":405},"NCT04530747","Metabolic Effects of Metformin Therapy in Obstructive Sleep Apnea",[54,55],"2021-11-30","2021-01-28",16,[404],"Sleep Apnea, Obstructive",[388],{"trials":407,"activeCount":65},[],{"trials":409,"activeCount":65},[],{"trials":411,"activeCount":65},[],{"intervention":413,"totalTrials":9,"cells":414},"Insulin, Regular, Human",{"EARLY_PHASE1":415,"PHASE1":417,"PHASE2":429,"PHASE3":431,"PHASE4":433,"NA":435},{"trials":416,"activeCount":65},[],{"trials":418,"activeCount":65},[419],{"nctId":420,"briefTitle":421,"status":91,"phases":422,"primaryCompletion":423,"completion":423,"start":424,"enrollment":425,"conditions":426,"interventions":428},"NCT04739371","Food Intake and Intra-Nasal Insulin for African American Adults (FIINAAL)",[54],"2022-06-07","2021-06-17",40,[427],"Insulin",[413],{"trials":430,"activeCount":65},[],{"trials":432,"activeCount":65},[],{"trials":434,"activeCount":65},[],{"trials":436,"activeCount":65},[],{"intervention":438,"totalTrials":9,"cells":439},"Diltiazem",{"EARLY_PHASE1":440,"PHASE1":442,"PHASE2":453,"PHASE3":455,"PHASE4":457,"NA":459},{"trials":441,"activeCount":65},[],{"trials":443,"activeCount":65},[444],{"nctId":445,"briefTitle":446,"status":259,"phases":447,"primaryCompletion":448,"completion":448,"start":449,"enrollment":22,"conditions":450,"interventions":452},"NCT01021176","Evaluate a Medication on How Hunger and Appetite Are Influenced by Smell",[54],"2009-11","2009-10",[451],"Food Intake",[438],{"trials":454,"activeCount":65},[],{"trials":456,"activeCount":65},[],{"trials":458,"activeCount":65},[],{"trials":460,"activeCount":65},[],{"intervention":462,"totalTrials":9,"cells":463},"Intralipid",{"EARLY_PHASE1":464,"PHASE1":475,"PHASE2":477,"PHASE3":479,"PHASE4":481,"NA":483},{"trials":465,"activeCount":65},[466],{"nctId":467,"briefTitle":468,"status":91,"phases":469,"primaryCompletion":470,"completion":470,"start":471,"enrollment":139,"conditions":472,"interventions":473},"NCT02697201","Dynamics of Muscle Mitochondria in Type 2 Diabetes (DYNAMMO T2D)",[53],"2021-05","2016-07",[21],[462,474],"Saline",{"trials":476,"activeCount":65},[],{"trials":478,"activeCount":65},[],{"trials":480,"activeCount":65},[],{"trials":482,"activeCount":65},[],{"trials":484,"activeCount":65},[],{"intervention":474,"totalTrials":9,"cells":486},{"EARLY_PHASE1":487,"PHASE1":493,"PHASE2":495,"PHASE3":497,"PHASE4":499,"NA":501},{"trials":488,"activeCount":65},[489],{"nctId":467,"briefTitle":468,"status":91,"phases":490,"primaryCompletion":470,"completion":470,"start":471,"enrollment":139,"conditions":491,"interventions":492},[53],[21],[462,474],{"trials":494,"activeCount":65},[],{"trials":496,"activeCount":65},[],{"trials":498,"activeCount":65},[],{"trials":500,"activeCount":65},[],{"trials":502,"activeCount":65},[],{"intervention":504,"totalTrials":9,"cells":505},"TSEC",{"EARLY_PHASE1":506,"PHASE1":517,"PHASE2":519,"PHASE3":521,"PHASE4":523,"NA":525},{"trials":507,"activeCount":65},[508],{"nctId":509,"briefTitle":510,"status":91,"phases":511,"primaryCompletion":512,"completion":512,"start":513,"enrollment":25,"conditions":514,"interventions":516},"NCT02274571","Raising Insulin Sensitivity in Post Menopause",[53],"2017-04-11","2015-09",[515],"Menopause",[504],{"trials":518,"activeCount":65},[],{"trials":520,"activeCount":65},[],{"trials":522,"activeCount":65},[],{"trials":524,"activeCount":65},[],{"trials":526,"activeCount":65},[],{"intervention":528,"totalTrials":9,"cells":529},"2mg of Albuterol",{"EARLY_PHASE1":530,"PHASE1":548,"PHASE2":550,"PHASE3":552,"PHASE4":554,"NA":556},{"trials":531,"activeCount":65},[532],{"nctId":533,"briefTitle":534,"status":91,"phases":535,"primaryCompletion":536,"completion":536,"start":537,"enrollment":25,"conditions":538,"interventions":540},"NCT02135965","Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate",[53],"2011-08","2009-04",[539],"Healthy Volunteers",[528,541,542,543,544,545,546,547],"4mg of Albuterol","100mg of Caffeine","200mg of Caffeine","Albuterol 2mg & Caffeine 100mg","Albuterol 2mg and Caffeine 200mg","Albuterol 4mg and Caffeine 100mg","Albuterol 4mg and Caffeine 200mg",{"trials":549,"activeCount":65},[],{"trials":551,"activeCount":65},[],{"trials":553,"activeCount":65},[],{"trials":555,"activeCount":65},[],{"trials":557,"activeCount":65},[],{"intervention":541,"totalTrials":9,"cells":559},{"EARLY_PHASE1":560,"PHASE1":566,"PHASE2":568,"PHASE3":570,"PHASE4":572,"NA":574},{"trials":561,"activeCount":65},[562],{"nctId":533,"briefTitle":534,"status":91,"phases":563,"primaryCompletion":536,"completion":536,"start":537,"enrollment":25,"conditions":564,"interventions":565},[53],[539],[528,541,542,543,544,545,546,547],{"trials":567,"activeCount":65},[],{"trials":569,"activeCount":65},[],{"trials":571,"activeCount":65},[],{"trials":573,"activeCount":65},[],{"trials":575,"activeCount":65},[],{"intervention":542,"totalTrials":9,"cells":577},{"EARLY_PHASE1":578,"PHASE1":584,"PHASE2":586,"PHASE3":588,"PHASE4":590,"NA":592},{"trials":579,"activeCount":65},[580],{"nctId":533,"briefTitle":534,"status":91,"phases":581,"primaryCompletion":536,"completion":536,"start":537,"enrollment":25,"conditions":582,"interventions":583},[53],[539],[528,541,542,543,544,545,546,547],{"trials":585,"activeCount":65},[],{"trials":587,"activeCount":65},[],{"trials":589,"activeCount":65},[],{"trials":591,"activeCount":65},[],{"trials":593,"activeCount":65},[],{"intervention":543,"totalTrials":9,"cells":595},{"EARLY_PHASE1":596,"PHASE1":602,"PHASE2":604,"PHASE3":606,"PHASE4":608,"NA":610},{"trials":597,"activeCount":65},[598],{"nctId":533,"briefTitle":534,"status":91,"phases":599,"primaryCompletion":536,"completion":536,"start":537,"enrollment":25,"conditions":600,"interventions":601},[53],[539],[528,541,542,543,544,545,546,547],{"trials":603,"activeCount":65},[],{"trials":605,"activeCount":65},[],{"trials":607,"activeCount":65},[],{"trials":609,"activeCount":65},[],{"trials":611,"activeCount":65},[],{"intervention":544,"totalTrials":9,"cells":613},{"EARLY_PHASE1":614,"PHASE1":620,"PHASE2":622,"PHASE3":624,"PHASE4":626,"NA":628},{"trials":615,"activeCount":65},[616],{"nctId":533,"briefTitle":534,"status":91,"phases":617,"primaryCompletion":536,"completion":536,"start":537,"enrollment":25,"conditions":618,"interventions":619},[53],[539],[528,541,542,543,544,545,546,547],{"trials":621,"activeCount":65},[],{"trials":623,"activeCount":65},[],{"trials":625,"activeCount":65},[],{"trials":627,"activeCount":65},[],{"trials":629,"activeCount":65},[],{"intervention":545,"totalTrials":9,"cells":631},{"EARLY_PHASE1":632,"PHASE1":638,"PHASE2":640,"PHASE3":642,"PHASE4":644,"NA":646},{"trials":633,"activeCount":65},[634],{"nctId":533,"briefTitle":534,"status":91,"phases":635,"primaryCompletion":536,"completion":536,"start":537,"enrollment":25,"conditions":636,"interventions":637},[53],[539],[528,541,542,543,544,545,546,547],{"trials":639,"activeCount":65},[],{"trials":641,"activeCount":65},[],{"trials":643,"activeCount":65},[],{"trials":645,"activeCount":65},[],{"trials":647,"activeCount":65},[],{"intervention":546,"totalTrials":9,"cells":649},{"EARLY_PHASE1":650,"PHASE1":656,"PHASE2":658,"PHASE3":660,"PHASE4":662,"NA":664},{"trials":651,"activeCount":65},[652],{"nctId":533,"briefTitle":534,"status":91,"phases":653,"primaryCompletion":536,"completion":536,"start":537,"enrollment":25,"conditions":654,"interventions":655},[53],[539],[528,541,542,543,544,545,546,547],{"trials":657,"activeCount":65},[],{"trials":659,"activeCount":65},[],{"trials":661,"activeCount":65},[],{"trials":663,"activeCount":65},[],{"trials":665,"activeCount":65},[],{"intervention":547,"totalTrials":9,"cells":667},{"EARLY_PHASE1":668,"PHASE1":674,"PHASE2":676,"PHASE3":678,"PHASE4":680,"NA":682},{"trials":669,"activeCount":65},[670],{"nctId":533,"briefTitle":534,"status":91,"phases":671,"primaryCompletion":536,"completion":536,"start":537,"enrollment":25,"conditions":672,"interventions":673},[53],[539],[528,541,542,543,544,545,546,547],{"trials":675,"activeCount":65},[],{"trials":677,"activeCount":65},[],{"trials":679,"activeCount":65},[],{"trials":681,"activeCount":65},[],{"trials":683,"activeCount":65},[],{"intervention":361,"totalTrials":11,"cells":685},{"EARLY_PHASE1":686,"PHASE1":688,"PHASE2":690,"PHASE3":696,"PHASE4":698,"NA":708},{"trials":687,"activeCount":65},[],{"trials":689,"activeCount":65},[],{"trials":691,"activeCount":65},[692],{"nctId":353,"briefTitle":354,"status":91,"phases":693,"completion":356,"start":357,"enrollment":358,"conditions":694,"interventions":695},[55],[15],[344,361,362],{"trials":697,"activeCount":65},[],{"trials":699,"activeCount":65},[700],{"nctId":701,"briefTitle":702,"status":91,"phases":703,"primaryCompletion":261,"completion":261,"start":704,"enrollment":112,"conditions":705,"interventions":707},"NCT00402012","\"TAKE TIME\" Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DM",[57],"2006-11",[706],"Diabetes Mellitus, Type 2",[361],{"trials":709,"activeCount":65},[710],{"nctId":711,"briefTitle":712,"status":91,"phases":713,"primaryCompletion":308,"completion":308,"start":714,"enrollment":715,"conditions":716,"interventions":718},"NCT01748994","Cellular Dynamics of Subcutaneous Fat Distribution in Obese Women",[58],"2011-02",63,[15,717],"Metabolic Syndrome",[361],{"intervention":720,"totalTrials":61,"cells":721},"Chromium Picolinate",{"EARLY_PHASE1":722,"PHASE1":724,"PHASE2":726,"PHASE3":728,"PHASE4":730,"NA":740},{"trials":723,"activeCount":65},[],{"trials":725,"activeCount":65},[],{"trials":727,"activeCount":65},[],{"trials":729,"activeCount":65},[],{"trials":731,"activeCount":65},[732],{"nctId":733,"briefTitle":734,"status":91,"phases":735,"primaryCompletion":357,"completion":736,"start":737,"enrollment":288,"conditions":738,"interventions":739},"NCT00283777","Chromium and Insulin Action",[57],"2003-04","1998-08",[29],[720],{"trials":741,"activeCount":65},[742],{"nctId":743,"briefTitle":744,"status":91,"phases":745,"primaryCompletion":746,"completion":746,"start":747,"enrollment":748,"conditions":749,"interventions":751},"NCT00477854","Effects of Chromium Picolinate on Food Intake",[58],"2007-05","2005-04",42,[15,750],"Atypical Depression",[720],{"intervention":753,"totalTrials":9,"cells":754},"Orlistat",{"EARLY_PHASE1":755,"PHASE1":757,"PHASE2":759,"PHASE3":761,"PHASE4":763,"NA":765},{"trials":756,"activeCount":65},[],{"trials":758,"activeCount":65},[],{"trials":760,"activeCount":65},[],{"trials":762,"activeCount":65},[],{"trials":764,"activeCount":65},[],{"trials":766,"activeCount":65},[767],{"nctId":768,"briefTitle":769,"status":770,"phases":771,"primaryCompletion":772,"completion":772,"start":773,"enrollment":65,"conditions":774,"interventions":775},"NCT01719419","The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects","WITHDRAWN",[58],"2012-09","2012-03",[31],[753],{"intervention":777,"totalTrials":9,"cells":778},"Amino acid supplement first day",{"EARLY_PHASE1":779,"PHASE1":781,"PHASE2":783,"PHASE3":785,"PHASE4":787,"NA":789},{"trials":780,"activeCount":65},[],{"trials":782,"activeCount":65},[],{"trials":784,"activeCount":65},[],{"trials":786,"activeCount":65},[],{"trials":788,"activeCount":65},[],{"trials":790,"activeCount":65},[791],{"nctId":792,"briefTitle":793,"status":91,"phases":794,"primaryCompletion":795,"completion":796,"start":797,"enrollment":402,"conditions":798,"interventions":801},"NCT02987868","Effects of an Amino Acid-Based hGH Secretagogue on Triiodythyronine",[58],"2011-12","2012-12","2011-10",[799,800],"Growth Hormone Treatment","Aging",[777,802],"Amino acid supplement second day",{"intervention":802,"totalTrials":9,"cells":804},{"EARLY_PHASE1":805,"PHASE1":807,"PHASE2":809,"PHASE3":811,"PHASE4":813,"NA":815},{"trials":806,"activeCount":65},[],{"trials":808,"activeCount":65},[],{"trials":810,"activeCount":65},[],{"trials":812,"activeCount":65},[],{"trials":814,"activeCount":65},[],{"trials":816,"activeCount":65},[817],{"nctId":792,"briefTitle":793,"status":91,"phases":818,"primaryCompletion":795,"completion":796,"start":797,"enrollment":402,"conditions":819,"interventions":820},[58],[799,800],[777,802],{"intervention":822,"totalTrials":9,"cells":823},"Amino acid supplement",{"EARLY_PHASE1":824,"PHASE1":826,"PHASE2":828,"PHASE3":830,"PHASE4":832,"NA":834},{"trials":825,"activeCount":65},[],{"trials":827,"activeCount":65},[],{"trials":829,"activeCount":65},[],{"trials":831,"activeCount":65},[],{"trials":833,"activeCount":65},[],{"trials":835,"activeCount":65},[836],{"nctId":837,"briefTitle":838,"status":91,"phases":839,"primaryCompletion":795,"completion":773,"start":797,"enrollment":402,"conditions":840,"interventions":843},"NCT01540773","Single Low-Dose of Supplement Amino Acid",[58],[841,842],"Growth Hormone","Amino Acid",[822],{"intervention":845,"totalTrials":9,"cells":846},"Assessment of sleep and related factors",{"EARLY_PHASE1":847,"PHASE1":849,"PHASE2":851,"PHASE3":853,"PHASE4":855,"NA":857},{"trials":848,"activeCount":65},[],{"trials":850,"activeCount":65},[],{"trials":852,"activeCount":65},[],{"trials":854,"activeCount":65},[],{"trials":856,"activeCount":65},[],{"trials":858,"activeCount":65},[859],{"nctId":860,"briefTitle":861,"status":91,"phases":862,"primaryCompletion":863,"completion":863,"start":864,"enrollment":865,"conditions":866,"interventions":867},"NCT05102188","Addressing Health Disparities in African Americans - Exploring Sleep and Developing Interventions - 2",[],"2022-12-31","2022-03-11",80,[166],[845],{"intervention":869,"totalTrials":9,"cells":870},"Caffeine 100mg \u002F Albuterol 4mg",{"EARLY_PHASE1":871,"PHASE1":873,"PHASE2":875,"PHASE3":877,"PHASE4":879,"NA":881},{"trials":872,"activeCount":65},[],{"trials":874,"activeCount":65},[],{"trials":876,"activeCount":65},[],{"trials":878,"activeCount":65},[],{"trials":880,"activeCount":65},[],{"trials":882,"activeCount":65},[883],{"nctId":884,"briefTitle":885,"status":91,"phases":886,"primaryCompletion":887,"completion":888,"start":174,"enrollment":22,"conditions":889,"interventions":891},"NCT02740660","Body Composition Changes With Albuterol and Caffeine Versus Placebo in Adolescents",[58],"2017-10-24","2017-10-31",[890],"Pediatric Obesity",[869],{"intervention":893,"totalTrials":9,"cells":894},"'Drug-Induced Menopause' Group",{"EARLY_PHASE1":895,"PHASE1":897,"PHASE2":899,"PHASE3":901,"PHASE4":903,"NA":905},{"trials":896,"activeCount":65},[],{"trials":898,"activeCount":65},[],{"trials":900,"activeCount":65},[],{"trials":902,"activeCount":65},[],{"trials":904,"activeCount":65},[],{"trials":906,"activeCount":65},[907],{"nctId":908,"briefTitle":909,"status":770,"phases":910,"primaryCompletion":911,"completion":911,"start":912,"enrollment":65,"conditions":913,"interventions":919},"NCT03856268","Understanding the Roles of Hormones in Adipocyte Remodeling Following Menopause",[],"2022-11-11","2019-04-01",[914,915,916,917,918],"Menopause Surgical","Estrogen Deficiency","Adiposity","Follicle-Stimulating Hormone Deficiency","Hormone Deficiency",[893],{"intervention":921,"totalTrials":9,"cells":922},"caffeine and ephedrine",{"EARLY_PHASE1":923,"PHASE1":925,"PHASE2":927,"PHASE3":929,"PHASE4":931,"NA":933},{"trials":924,"activeCount":65},[],{"trials":926,"activeCount":65},[],{"trials":928,"activeCount":65},[],{"trials":930,"activeCount":65},[],{"trials":932,"activeCount":65},[],{"trials":934,"activeCount":65},[935],{"nctId":936,"briefTitle":937,"status":91,"phases":938,"primaryCompletion":939,"completion":939,"start":940,"enrollment":941,"conditions":942,"interventions":943},"NCT01710722","The Effect of Leptin A-200, Caffeine\u002FEphedrine and Their Combination Upon Weight Loss and Body Composition in Man",[58],"2002-02","2001-02",45,[15],[921,944,945],"Leptin A","caffeine, ephedrine, and leptin A",{"intervention":944,"totalTrials":9,"cells":947},{"EARLY_PHASE1":948,"PHASE1":950,"PHASE2":952,"PHASE3":954,"PHASE4":956,"NA":958},{"trials":949,"activeCount":65},[],{"trials":951,"activeCount":65},[],{"trials":953,"activeCount":65},[],{"trials":955,"activeCount":65},[],{"trials":957,"activeCount":65},[],{"trials":959,"activeCount":65},[960],{"nctId":936,"briefTitle":937,"status":91,"phases":961,"primaryCompletion":939,"completion":939,"start":940,"enrollment":941,"conditions":962,"interventions":963},[58],[15],[921,944,945],{"intervention":945,"totalTrials":9,"cells":965},{"EARLY_PHASE1":966,"PHASE1":968,"PHASE2":970,"PHASE3":972,"PHASE4":974,"NA":976},{"trials":967,"activeCount":65},[],{"trials":969,"activeCount":65},[],{"trials":971,"activeCount":65},[],{"trials":973,"activeCount":65},[],{"trials":975,"activeCount":65},[],{"trials":977,"activeCount":65},[978],{"nctId":936,"briefTitle":937,"status":91,"phases":979,"primaryCompletion":939,"completion":939,"start":940,"enrollment":941,"conditions":980,"interventions":981},[58],[15],[921,944,945]]